Medicine and Dentistry
Ganglioglioma
100%
Quality of Life
86%
Prostate Cancer
60%
Systematic Review
60%
Health Care Cost
56%
Sulfhemoglobinemia
40%
Dexamethasone
40%
Malignant Neoplasm
38%
Primary Health Care
27%
Patient-Reported Outcome
25%
Randomized Controlled Trial
24%
Nurse
22%
Cost Benefit Analysis
20%
Sore Throat
20%
Kidney Transplantation
20%
Cancer Therapy
20%
Cancer Registry
20%
Critical Appraisal
20%
Checklist
20%
Prostatectomy
20%
Oligodendroglioma
20%
Machine Perfusion
20%
Cancer Screening
20%
Inflammatory Bowel Disease
20%
Cost-Effectiveness Analysis
17%
Disease
16%
Self Concept
16%
Health Care
14%
High-Intensity Focused Ultrasound
14%
Epileptic Seizure
12%
Transplantation
11%
Placebo
11%
Cognitive Defect
10%
Work Capacity
10%
Work Environment
10%
Intracranial Tumor
10%
Gastroenterology
10%
Diseases
10%
Transplantation Research
10%
Autism
10%
Health Literacy
10%
Translational Medicine
10%
Health Information Technology
10%
Glomerular Filtration Rate
8%
Emotion
8%
Single Drug Dose
8%
Arm
8%
Wellbeing
8%
Multivariate Analysis
8%
Supportive Care
6%
Psychology
Self-Management
80%
Quality of Life
55%
Caregiver
43%
Systematic Review
40%
Qualitative Method
40%
Prostate Cancer
40%
Semistructured Interview
39%
Qualitative Study
38%
Thematic Analysis
32%
Self-Efficacy
20%
Psychological Distress
20%
Work Environment
20%
Family Income
20%
Emotional Support
20%
Helplessness
20%
Emotional Consequence
20%
Burnout
20%
Study Design
20%
Needs Assessment
20%
Cognitive Deficit
17%
Behavioral Disorder
13%
Psychology
13%
Healthcare Professional
13%
Healthcare
6%
Wellbeing
6%
Nursing and Health Professions
Prostate Cancer
43%
Dexamethasone
40%
Economic Analysis
26%
Primary Medical Care
25%
Quality of Life
22%
Sore Throat
20%
Castration Resistant Prostate Cancer
20%
Prostatectomy
20%
High Intensity Focused Ultrasound
20%
Gonorrhea
20%
Cancer Screening
20%
Health Economics
20%
Inflammatory Bowel Disease
20%
Placebo
11%
Self-Efficacy
10%
Public Health Informatics
10%
Health Literacy
10%
Diseases
10%
Cost Effectiveness Analysis
9%
Incremental Cost-Effectiveness Ratio
8%
Single Drug Dose
8%
Randomization
8%
Patient-Reported Outcome
8%
Health Service
7%
Malignant Neoplasm
7%
Urinary Tract Infection
6%
Pelvic Inflammatory Disease
6%
Secondary Health Care
5%
Care Group
5%
Intracranial Tumor
5%
